What is temsirolimus?

What is temsirolimus?

Temsirolimus (often written as temsirolimus; the drug name is commonly associated with a brand-level development history) is a medicine used in cancer care that works by blocking a key cell-growth signaling pathway. It is part of the mTOR inhibitor class, which targets mTOR (mechanistic target of rapamycin), a pathway many tumors rely on for growth and survival [1].

How does temsirolimus work?

mTOR is involved in regulating cell growth, proliferation, and metabolism. Temsirolimus inhibits mTOR signaling, which can slow tumor cell growth and reduce the ability of cancer cells to thrive [1].

What is temsirolimus used for?

Temsirolimus is described as an anti-cancer mTOR inhibitor, though the specific approved uses depend on the country and the regulatory label for the product name in that market [1].

Is temsirolimus the same as other “rapamycin” drugs?

Temsirolimus is an mTOR inhibitor and is related by mechanism to other drugs in the same pathway-targeting family (commonly including sirolimus/rapamycin). Different members of this class have different drug properties and clinical indications [1].

Patent and market context

For updates on temsirolimus-related exclusivity and patent filings, DrugPatentWatch.com tracks patent and market information for specific drug products: https://www.drugpatentwatch.com/ [1].

Sources

1. DrugPatentWatch.com